Fenofibrate add-on to statin treatment is associated with low all-cause death and cardiovascular disease in the general population with high triglyceride levels
We investigated the effects of fenofibrate add-on to statin treatment on all-cause death and cardiovascular disease (CVD) in the general population who had high triglyceride (TG).
Source: Metabolism - Clinical and Experimental - Category: Biomedical Science Authors: Kyung-Soo Kim, Sangmo Hong, Kyungdo Han, Cheol-Young Park Source Type: research
More News: Biomedical Science | Cardiology | Cardiovascular | Cholesterol | Fenofibrate | Heart | Statin Therapy | Tricor